DoD Peer Reviewed Medical Research Program, Clinical Trial Award
ID: 358888Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358888
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity under the Peer Reviewed Medical Research Program (PRMRP) for the fiscal year 2025, specifically for the Clinical Trial Award (CTA). This program aims to support the rapid implementation of clinical trials that can significantly impact the treatment or management of diseases relevant to military health, with a focus on areas such as autoimmune disorders, cardiovascular health, infectious diseases, and neuroscience. Approximately $32 million is available for this initiative, with an expected four awards, each capped at $8 million, and applications are due by July 21, 2025. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525PRMRPCTA-GG.pdf
    The Department of Defense (DOD) has issued a Program Announcement for the Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award (Funding Opportunity Number: HT942525PRMRPCTA) for fiscal year 2025. This initiative focuses on the rapid implementation of clinical trials that significantly impact disease treatment and management relevant to military health. Approximately $32 million is allocated for about four awards, each capped at $8 million, with applications due by July 21, 2025. Eligible applicants include various organizations, both domestic and foreign, public and private. The application process consists of a two-step approach, requiring a pre-application followed by a full application. The program prioritizes clinical trials over animal studies, mandating that preclinical work must be completed prior to the award start date. Key topic areas include autoimmune disorders, cardiovascular health, infectious diseases, neuroscience, and more, each with specific strategic goals that applicants must address. The program aims to enhance military health by promoting significant research advancements, encouraging collaboration between academia, government, and industry to address the military's unique health needs. Regulatory agency approvals are essential for interventions, emphasizing rigorous safety and ethical standards.
    Similar Opportunities
    DOD Peer Reviewed Cancer, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity for the fiscal year 2025 under the Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA). This grant aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment, specifically targeting designated cancer types relevant to military health. The program emphasizes the importance of advancing cancer research to benefit service members, veterans, and their families, with funding available for projects ranging from initial proof-of-concept trials to large-scale phase III trials, capped at a total cost of $4.2 million over a maximum performance period of four years. Interested applicants must submit pre-applications by June 20, 2025, followed by full applications due by September 25, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Duchenne Muscular Dystrophy, Clinical/Translational Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity for the Duchenne Muscular Dystrophy Research Program's Clinical/Translational Research Award (CTRA) for fiscal year 2025. This funding initiative aims to support advanced translational research that accelerates promising ideas in Duchenne muscular dystrophy (DMD) into clinical applications, particularly focusing on therapies effective across all age groups, including infants and nonambulatory individuals. With an estimated total program funding of approximately $8.56 million, the program anticipates awarding around five grants, encouraging collaborations with early-career investigators and requiring applications to include preliminary data relevant to DMD. Interested applicants should note that a pre-application is due by July 25, 2025, with full applications due by August 8, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Medical Research Program, Technology/Therapeutic Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA) to support the translation of promising preclinical findings into clinical applications for military personnel, veterans, and their families. This grant aims to facilitate the development of products that address military-related health challenges, including prevention, detection, diagnosis, treatment, or quality of life improvements, with a focus on innovative approaches in areas such as autoimmune disorders and infectious diseases. With an estimated total program funding of approximately $41.25 million available for up to 11 awards, applicants must submit a two-step application process, including a pre-application and a full application, by the closing date of July 21, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Peer Reviewed Cancer, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the fiscal year 2025 Peer Reviewed Cancer Research Program (PRCRP) Idea Award to support innovative cancer research that prioritizes military health. This grant aims to fund high-risk, high-reward proposals that focus on specific cancer types relevant to Service Members, Veterans, and their families, with an emphasis on introducing new paradigms in cancer care and addressing environmental exposure risks. With an estimated total program funding of approximately $14 million, the program anticipates awarding around 25 projects, each with a maximum funding limit of $560,000 for a duration of up to two years. Interested applicants must submit a pre-application by June 20, 2025, followed by a full application due by September 25, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Impact Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Impact Award to support high-impact research aimed at improving clinical cancer care relevant to military health. This grant seeks mature research projects that demonstrate potential for near-term benefits in cancer treatment and patient outcomes, particularly focusing on specific cancer types such as bladder, blood, and brain cancers, while excluding melanoma and breast cancers. The program emphasizes the importance of preliminary data, collaboration with Department of Defense (DOD) and Veterans Affairs (VA) entities, and rigorous study designs to advance cancer detection and treatment for service members and their families. The estimated total program funding is $45.5 million, with individual awards capped at $1.4 million for single Principal Investigator applications and $1.75 million for partnering applications, over a maximum period of three years. Interested applicants must submit a pre-application by September 25, 2025, and can contact the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Toxic Exposures Clinical Trial Partnership Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY25 Toxic Exposures Research Program (TERP) Clinical Trial Partnership Award (CTPA), aimed at supporting collaborative clinical trials focused on health issues related to military-related toxic exposures. The initiative seeks to rapidly implement studies that address the prevention, treatment, and management of diseases or symptoms resulting from such exposures, with an estimated total program funding of $4.2 million available for this purpose. Eligible applicants include a wide range of nonprofit and for-profit organizations, with a requirement for partnerships involving multiple Principal Investigators (PIs) to enhance collaboration and research efficacy. Interested parties should note that the application process involves a two-step submission of a pre-application and full application, with a closing date set for October 16, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DHA- Military Health System Research Program
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is offering a funding opportunity under the Military Health System Research Program (MHSRP) aimed at enhancing healthcare delivery within the Military Health System. This grant program seeks innovative research that addresses critical areas such as healthcare economics, quality, outcomes, and service member readiness, with the goal of supporting evidence-based decision-making within the Department of Defense. The total estimated funding for this program is $10 million, with an expected ten awards to be granted, and key deadlines include a Letter of Intent submission by July 9, 2025, and full proposals due by October 17, 2025. Interested applicants can reach out to the DHA MHSRP Mailbox at dha.ncr.j-9.mbx.hsr@health.mil for further information.
    DoD Prostate Cancer, Clinical Consortium Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2025 Prostate Cancer Research Program Clinical Consortium Award, aimed at advancing clinical trials for novel therapeutic interventions in prostate cancer. This grant supports the establishment of a consortium of leading researchers across multiple institutions to expedite the clinical advancement of treatments, with a focus on understanding disease progression, improving patient quality of life, and ensuring equitable access to care for high-risk populations. The total estimated funding for this opportunity is approximately $36.8 million, with $12.2 million allocated for one Coordinating Center and $24.6 million for up to eleven clinical research sites, each with specific funding caps and a duration of four years. Interested applicants must submit a pre-application by August 8, 2025, followed by a full application by August 29, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Career Development Award – Scholar Option
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025. This grant aims to support independent early-career investigators, referred to as Scholars, in conducting impactful cancer research under the mentorship of an experienced Career Guide, with a focus on military health-related cancer issues. The program has an estimated total funding of approximately $9.9 million, with about nine awards anticipated, each capped at $1.1 million. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Alzheimer’s Research Program Transforming Care Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Care Award to support innovative clinical research aimed at improving care for individuals with Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity encourages community collaboration and requires projects to focus on interventions that enhance the quality of life for both patients and their caregivers. Approximately $5.2 million is available to fund around three awards, with pre-applications due by June 12, 2025, and full applications due by August 29, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.